CME Group Inc [NASDAQ: CME] gained 0.94% on the last trading session, reaching $243.00 price per share at the time.
If compared to the average trading volume of 1.95M shares, CME reached a trading volume of 4393077 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Here is what top equities market gurus are saying about CME Group Inc [CME]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CME shares is $238.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CME stock is a recommendation set at 2.47. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Redburn Atlantic have made an estimate for CME Group Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on October 08, 2024. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Sector Perform. The new note on the price target was released on September 27, 2024, representing the official price target for CME Group Inc stock. Previously, the target price had yet another raise to $221, while TD Cowen analysts kept a Hold rating on CME stock. On September 03, 2024, analysts decreased their price target for CME shares from 212 to 177.
The Average True Range (ATR) for CME Group Inc is set at 4.04, with the Price to Sales ratio for CME stock in the period of the last 12 months amounting to 14.49. The Price to Book ratio for the last quarter was 3.10, with the Price to Cash per share for the same quarter was set at 6.77. Price to Free Cash Flow for CME in the course of the last twelve months was 24.13.
Trading performance analysis for CME stock
CME Group Inc [CME] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.67. With this latest performance, CME shares gained by 8.93% in over the last four-week period, additionally plugging by 21.20% over the last 6 months – not to mention a rise of 13.34% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CME stock in for the last two-week period is set at 72.01, with the RSI for the last a single of trading hit 76.47, and the three-weeks RSI is set at 69.00 for CME Group Inc [CME]. The present Moving Average for the last 50 days of trading for this stock 226.50, while it was recorded at 238.93 for the last single week of trading, and 212.88 for the last 200 days.
CME Group Inc [CME]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, CME Group Inc posted 2.37/share EPS, while the average EPS was predicted by analysts to be reported at 2.28/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.09. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CME. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CME Group Inc go to 4.24%.
An analysis of Institutional ownership at CME Group Inc [CME]
There are presently around $89.57%, or 89.98%% of CME stock, in the hands of institutional investors. The top three institutional holders of CME stocks are: VANGUARD GROUP INC with ownership of 33.57 million shares, which is approximately 9.344%. BLACKROCK INC., holding 25.66 million shares of the stock with an approximate value of $$5.05 billion in CME stocks shares; and BLACKROCK INC., currently with $$3.15 billion in CME stock with ownership which is approximately 4.4585%.
